Related Experiment Video
Updated: Jun 2, 2026
04:08
Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
Published on: April 28, 2026
[Efficacy of preparation metrogil in abdominal surgery]
Klinichna Khirurhiia
|May 10, 2011
Abstract:
There was summarized the experience of Metrogil (metronidazol, produced by company "Unique Pharmaceutical Laboratories", India) application for the treatment of anaerobic infection in diseases of hepatobiliary zone organs as well as for prophylaxis of purulent-septic complications in abdominal surgery.
Insights
Metrogil, containing metronidazole, effectively treats anaerobic infections in hepatobiliary diseases. It also prevents serious complications in abdominal surgery patients.
Area of Science:
- Hepatobiliary Medicine
- Surgical Infectious Diseases
- Pharmacology
Context:
- Anaerobic infections pose significant risks in hepatobiliary diseases.
- Preventing purulent-septic complications is crucial in abdominal surgery.
- Metrogil (metronidazole) is a key therapeutic agent.
Purpose:
- To summarize clinical experience with Metrogil for hepatobiliary anaerobic infections.
- To evaluate Metrogil's efficacy in preventing surgical site infections.
- To assess the prophylactic use of metronidazole in abdominal surgery.
Summary:
- The study reviews the application of Metrogil (metronidazole) in treating anaerobic infections affecting the hepatobiliary system.
- Experience with Metrogil for prophylaxis of purulent-septic complications in abdominal surgery is detailed.
- The findings highlight Metrogil's role in managing complex infections and preventing post-operative complications.
Impact:
- Provides evidence for Metrogil's utility in managing hepatobiliary infections.
- Informs clinical practice regarding the prophylactic use of metronidazole in surgery.
- Contributes to understanding the management of anaerobic infections in surgical and medical contexts.
